Enterovirus D68 Subclade B3 Circulation in Senegal, 2016: Detection from Influenza-like Illness and Acute Flaccid Paralysis Surveillance.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 09 2019
Historique:
received: 18 04 2019
accepted: 04 09 2019
entrez: 27 9 2019
pubmed: 27 9 2019
medline: 28 10 2020
Statut: epublish

Résumé

Following the 2014 outbreak, active surveillance of the EV-D68 has been implemented in many countries worldwide. Despite subsequent EV-D68 outbreaks (2014 and 2016) reported in many areas, EV-D68 circulation remains largely unexplored in Africa except in Senegal, where low levels of EV-D68 circulation were first noted during the 2014 outbreak. Here we investigate subsequent epidemiology of EV-D68 in Senegal from June to September 2016 by screening respiratory specimens from ILI and stool from AFP surveillance. EV-D68 was detected in 7.4% (44/596) of patients; 40 with ILI and 4 with AFP. EV-D68 detection was significantly more common in children under 5 years (56.8%, p = 0.016). All EV-D68 strains detected belonged to the newly defined subclade B3. This study provides the first evidence of EV-D68 B3 subclade circulation in Africa from patients with ILI and AFP during a 2016 outbreak in Senegal. Enhanced surveillance of EV-D68 is needed to better understand the epidemiology of EV-D68 in Africa.

Identifiants

pubmed: 31554908
doi: 10.1038/s41598-019-50470-z
pii: 10.1038/s41598-019-50470-z
pmc: PMC6761155
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

13881

Références

Pediatr Infect Dis J. 2019 Jan;38(1):16-21
pubmed: 30234793
Euro Surveill. 2018 Sep;23(37):
pubmed: 30229724
PLoS One. 2014 Jul 23;9(7):e102866
pubmed: 25054861
Eur J Paediatr Neurol. 2017 Nov;21(6):884-890
pubmed: 28747261
Lancet. 2015 Apr 25;385(9978):1662-71
pubmed: 25638662
J Clin Virol. 2018 Feb - Mar;99-100:91-96
pubmed: 29396353
Arch Argent Pediatr. 2017 Aug 1;115(4):364-369
pubmed: 28737865
Springerplus. 2016 Feb 24;5:158
pubmed: 27026855
PLoS One. 2014 Mar 27;9(3):e93227
pubmed: 24675982
J Microbiol Immunol Infect. 2017 Aug;50(4):411-417
pubmed: 26458357
Clin Infect Dis. 2016 Sep 15;63(6):737-745
pubmed: 27318332
Sci Rep. 2017 Apr 28;7(1):1242
pubmed: 28455514
J Gen Virol. 2012 Sep;93(Pt 9):1952-1958
pubmed: 22694903
Medicine (Baltimore). 2016 Aug;95(31):e4416
pubmed: 27495059
MMWR Morb Mortal Wkly Rep. 2017 Jul 21;66(28):758-760
pubmed: 28727681
J Clin Virol. 2017 Jul;92:39-41
pubmed: 28521212
J Clin Virol. 2017 Aug;93:40-44
pubmed: 28618288
J Microbiol Immunol Infect. 2018 Oct;51(5):688-691
pubmed: 29339008
MMWR Morb Mortal Wkly Rep. 2014 Sep 12;63(36):798-9
pubmed: 25211545
J Clin Microbiol. 2015 May;53(5):1725-6
pubmed: 25694533
Euro Surveill. 2016 Nov 17;21(46):
pubmed: 27918268
Emerg Infect Dis. 2019 Jul;25(7):1404-1407
pubmed: 31211670
MMWR Morb Mortal Wkly Rep. 2017 Aug 11;66(31):826-829
pubmed: 28796760
J Emerg Med. 2017 Jul;53(1):e19-e23
pubmed: 28412073
Emerg Infect Dis. 2019 Mar;25(3):573-576
pubmed: 30602120
MMWR Morb Mortal Wkly Rep. 2011 Sep 30;60(38):1301-4
pubmed: 21956405
PLoS Pathog. 2017 Feb 23;13(2):e1006199
pubmed: 28231269
Clin Infect Dis. 2018 Feb 10;66(5):653-664
pubmed: 29028962
Pediatr Infect Dis J. 2017 Dec;36(12):1214-1216
pubmed: 28661963
Influenza Other Respir Viruses. 2017 May;11(3):211-219
pubmed: 28122175
Euro Surveill. 2016 Nov 17;21(46):
pubmed: 27918255
Ann Am Thorac Soc. 2015 May;12(5):775-81
pubmed: 25714788
Emerg Infect Dis. 2016 Aug;22(8):1387-94
pubmed: 27434186
Lancet Infect Dis. 2016 May;16(5):e64-e75
pubmed: 26929196
Medicine (Baltimore). 2018 Sep;97(36):e11831
pubmed: 30200066
Lancet Infect Dis. 2015 Jun;15(6):671-82
pubmed: 25837569
J Med Virol. 2017 Oct;89(10):1759-1767
pubmed: 28574589
Emerg Infect Dis. 2017 Jan;23(1):140-143
pubmed: 27660916
Diagn Microbiol Infect Dis. 2016 Jun;85(2):174-6
pubmed: 27036976

Auteurs

Amary Fall (A)

Institut Pasteur de Dakar, Département de Virologie, Dakar, Senegal.

Ndack Ndiaye (N)

Institut Pasteur de Dakar, Département de Virologie, Dakar, Senegal.

Mamadou Malado Jallow (MM)

Institut Pasteur de Dakar, Département de Virologie, Dakar, Senegal.

Mamadou Aliou Barry (MA)

Institut Pasteur de Dakar, Unité d'Epidémiologie des maladies infectieuses, Dakar, Senegal.

Cheikh Saad Bou Touré (CSB)

Institut Pasteur de Dakar, Département de Virologie, Dakar, Senegal.

Ousmane Kebe (O)

Institut Pasteur de Dakar, Département de Virologie, Dakar, Senegal.

Davy Evrard Kiori (DE)

Institut Pasteur de Dakar, Département de Virologie, Dakar, Senegal.

Sara Sy (S)

Institut Pasteur de Dakar, Département de Virologie, Dakar, Senegal.

Mohamed Dia (M)

Institut Pasteur de Dakar, Département de Virologie, Dakar, Senegal.

Déborah Goudiaby (D)

Institut Pasteur de Dakar, Département de Virologie, Dakar, Senegal.

Kader Ndiaye (K)

Institut Pasteur de Dakar, Département de Virologie, Dakar, Senegal.

Mbayame Ndiaye Niang (MN)

Institut Pasteur de Dakar, Département de Virologie, Dakar, Senegal.

Ndongo Dia (N)

Institut Pasteur de Dakar, Département de Virologie, Dakar, Senegal. ndia@pasteur.sn.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH